Related Experiment Video
Updated: Jul 13, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
An institutional process to improve inpatient glycemic control
L Raymond Reynolds1, Aaron M Cook, Daniel A Lewis
1University of Kentucky Chandler Medical Center, Department of Medicine, Division of Endocrinology, Lexington, KY 40536, USA. Lrreyn2@uky.edu
Quality Management in Health Care
|July 14, 2007
Summary
Improving inpatient hyperglycemia care involves a structured approach. Implementing standardized protocols and extensive education enhances glycemic control and reduces reliance on sliding scale insulin.
Area of Science:
- Internal Medicine
- Endocrinology
- Hospital Administration
Background:
- Inpatient hyperglycemia management is critical for patient outcomes.
- Evidence supports strict glycemic control in various hospital settings.
- Institutions are reviewing care patterns for diabetic patients.
Purpose of the Study:
- To describe a stepwise process for improving inpatient hyperglycemia care.
- To enhance the quality and safety of care for hyperglycemic inpatients.
- To implement standardized protocols and procedures.
Main Methods:
- Established a multidisciplinary task force.
- Examined existing procedures and adopted standards.
- Developed and implemented common protocols.
- Conducted extensive staff education.
- Refined protocols based on feedback.
Main Results:
- Successful implementation of new protocols.
- Improvements in glycemic parameters observed.
- Reduced reliance on sliding scale insulin regimens.
- Enhanced quality and safety of care.
Conclusions:
- A systematic, multidisciplinary approach can significantly improve inpatient glycemic control.
- Standardized protocols, education, and continuous refinement are key to success.
- Optimized hyperglycemia management leads to better patient outcomes and efficient care delivery.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:14SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...